Inhibition of CK2α down-regulates Notch1 signalling in lung cancer cells

CD44+/CD24− ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival

(2012) Erhong Meng et al.   CLINICAL & EXPERIMENTAL METASTASIS

Inhibition of CK2α Down-Regulates Hedgehog/Gli Signaling Leading to a Reduction of a Stem-Like Side Population in Human Lung Cancer Cells

(2012) Shulin Zhang et al.   PLoS One

Notch signaling in lung cancer

(2011) Paola Galluzzo et al.   Expert Review of Anticancer Therapy

Hierarchical Interactions of Homeodomain and Forkhead Transcription Factors in Regulating Odontogenic Gene Expression

(2011) Shankar R. Venugopalan et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

CIGB-300, a synthetic peptide-based drug that targets the CK2 phosphoaceptor domain. Translational and clinical research

(2011) Silvio E. Perea et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Pre-clinical characterization of CX-4945, a potent and selective small molecule inhibitor of CK2 for the treatment of cancer

(2011) Fabrice Pierre et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Notch1 Inhibition Alters the CD44hi/CD24lo Population and Reduces the Formation of Brain Metastases from Breast Cancer

(2011) P. M. McGowan et al.   MOLECULAR CANCER RESEARCH

Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma

(2011) N. J. Wang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Overexpression of Nuclear Protein Kinase CK2 β Subunit and Prognosis in Human Gastric Carcinoma

(2010) Kai-Yuan Lin et al.   ANNALS OF SURGICAL ONCOLOGY

Targeting CK2 overexpression and hyperactivation as a novel therapeutic tool in chronic lymphocytic leukemia

(2010) L. R. Martins et al.   BLOOD

Overexpression of ΔNp63α induces a stem cell phenotype in MCF7 breast carcinoma cell line through the Notch pathway

(2010) Zhijian Du et al.   CANCER SCIENCE

Discovery and SAR of 5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic Acid (CX-4945), the First Clinical Stage Inhibitor of Protein Kinase CK2 for the Treatment of Cancer

(2010) Fabrice Pierre et al.   JOURNAL OF MEDICINAL CHEMISTRY

The expression of CXCR4, CXCL12 and CXCR7 in malignant pleural mesothelioma

(2010) Tong Li et al.   JOURNAL OF PATHOLOGY

Resistance May Not Be Futile: microRNA Biomarkers for Chemoresistance and Potential Therapeutics

(2010) K. E. Allen et al.   MOLECULAR CANCER THERAPEUTICS

Notch-1 stimulates survival of lung adenocarcinoma cells during hypoxia by activating the IGF-1R pathway

(2010) S Eliasz et al.   ONCOGENE

Non-Small Cell Lung Cancer Cells Expressing CD44 Are Enriched for Stem Cell-Like Properties

(2010) Elaine Lai-Han Leung et al.   PLoS One

Addiction to protein kinase CK2: A common denominator of diverse cancer cells?

(2009) Maria Ruzzene et al.   BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS

Protein Kinase CK2 in Health and Disease

(2009) I. Dominguez et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Protein Kinase CK2 in Health and Disease

(2009) J. H. Trembley et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Alterations of the Notch pathway in lung cancer

(2009) Britta Westhoff et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Impact of protein kinase CK2 on inhibitor of apoptosis proteins in prostate cancer cells

(2008) Guixia Wang et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Too much of a good thing: The role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2

(2007) James S. Duncan et al.   BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS